Pancreatitis in children, often mistaken for minor digestive issues, can cause severe abdominal pain and requires timely ...

If you have acute pancreatitis, you will likely be advised by your medical team to stop eating and may be placed on IV fluids ...

A new prediction model for infected pancreatic necrosis (IPN) in patients with acute pancreatitis (AP) offers a groundbreaking approach to improving patient outcomes.

Nat Clin Pract Gastroenterol Hepatol. 2006;3(7):356-357. The cause of acute pancreatitis is easily identifiable in 70–90% of patients. In patients with idiopathic acute pancreatitis (IAP ...

US FDA approves Ionis Pharma’s Tryngolza to treat adults living with familial chylomicronemia syndrome as an adjunct to diet: Carlsbad, California Monday, December 23, 2024, 15: ...

CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis ... for acute and chronic inflammatory and ...

significantly reduces triglyceride levels in patients with severe hypertriglyceridemia (sHTG). The SHASTA-2 trial assessed ...

The US FDA has approved olezarsen (Tryngolza) as the first treatment for adults with familial chylomicronemia syndrome, a ...

Ionis Pharma's olezarsen has become the first FDA-approved drug therapy for adults with familial chylomicronaemia syndrome ...

The Food and Drug Administration (FDA) has approved Tryngolza™ (olezarsen) as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS).